A relationship between the aggregation rates of α-synuclein variants and the β-sheet populations in their monomeric forms

Journal of Physical Chemistry B

Volumn 117, Issue 37, 2013, Pages 10737-10741

  Camilloni, Carlo ^a   Vendruscolo, Michele ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; NEURODEGENERATIVE DISEASES; PROTEINS;

AGGREGATION BEHAVIOR; CONFORMATIONAL PROPERTIES; INTRINSICALLY DISORDERED PROTEINS; NEURODEGENERATIVE; NMR CHEMICAL SHIFTS; SECONDARY STRUCTURES; SYSTEMIC DISEASE; THERAPEUTIC STRATEGY;

POPULATION STATISTICS;

ALPHA SYNUCLEIN; BETA SYNUCLEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; MOUSE; MUTATION; NUCLEAR MAGNETIC RESONANCE; PROTEIN SECONDARY STRUCTURE;

ALPHA-SYNUCLEIN; ANIMALS; BETA-SYNUCLEIN; HUMANS; MICE; MODELS, MOLECULAR; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS;

EID: 84884507134     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp405614j     Document Type: Article

References (37)

1. Balch, W. E.; Morimoto, R. I.; Dillin, A.; Kelly, J. W. Adapting Proteostasis for Disease Intervention Science 2008, 319, 916-919
2. Chiti, F.; Dobson, C. M. Protein Misfolding, Functional Amyloid, and Human Disease Annu. Rev. Biochem. 2006, 75, 333-366
3. Haass, C.; Selkoe, D. J. Soluble Protein Oligomers in Neurodegeneration: Lessons from the Alzheimer's Amyloid Beta-Peptide Nat. Rev. Mol. Cell Biol. 2007, 8, 101-112
4. Spillantini, M. G.; Schmidt, M. L.; Lee, V. M. Y.; Trojanowski, J. Q.; Jakes, R.; Goedert, M. Alpha-Synuclein in Lewy Bodies Nature 1997, 388, 839-840
5. Dedmon, M. M.; Lindorff-Larsen, K.; Christodoulou, J.; Vendruscolo, M.; Dobson, C. M. Mapping Long-Range Interactions in Alpha-Synuclein Using Spin-Label NMR and Ensemble Molecular Dynamics Simulations J. Am. Chem. Soc. 2005, 127, 476-477
6. Thomas, B.; Beal, M. F. Parkinson's Disease Hum. Mol. Genet. 2007, 16, R183-R194
7. Lees, A. J.; Hardy, J.; Revesz, T. Parkinson's Disease Lancet 2009, 373, 2055-2066
8. Auluck, P. K.; Caraveo, G.; Lindquist, S. Alpha-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease Annu. Rev. Cell Dev. Biol. 2010, 26, 211-233
9. Bartels, T.; Choi, J. G.; Selkoe, D. J. Alpha-Synuclein Occurs Physiologically as a Helically Folded Tetramer That Resists Aggregation Nature 2011, 477, 107-U123
10. Conway, K. A.; Lee, S. J.; Rochet, J. C.; Ding, T. T.; Williamson, R. E.; Lansbury, P. T. Acceleration of Oligomerization, Not Fibrillization, Is a Shared Property of Both Alpha-Synuclein Mutations Linked to Early-Onset Parkinson's Disease: Implications for Pathogenesis and Therapy Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 571-576
11. Lashuel, H. A.; Petre, B. M.; Wall, J.; Simon, M.; Nowak, R. J.; Walz, T.; Lansbury, P. T. Alpha-Synuclein, Especially the Parkinson's Disease-Associated Mutants, Forms Pore-Like Annular and Tubular Protofibrils J. Mol. Biol. 2002, 322, 1089-1102
12. Uversky, V. N.; Eliezer, D. Biophysics of Parkinson's Disease: Structure and Aggregation of Alpha-Synuclein Curr. Protein Pept. Sci. 2009, 10, 483-499
13. Roodveldt, C.; Andersson, A.; De Genst, E. J.; Labrador-Garrido, A.; Buell, A. K.; Dobson, C. M.; Tartaglia, G. G.; Vendruscolo, M. A Rationally Designed Six-Residue Swap Generates Comparability in the Aggregation Behavior of Alpha-Synuclein and Beta-Synuclein Biochemistry 2012, 51, 8771-8778
14. Rabe, M.; Soragni, A.; Reynolds, N. P.; Verdes, D.; Liverani, E.; Riek, R.; Seeger, S. On-Surface Aggregation of Alpha-Synuclein at Nanomolar Concentrations Results in Two Distinct Growth Mechanisms ACS Chem. Neurosci. 2013, 4, 408-417
15. Giehm, L.; Oliveira, C. L. P.; Christiansen, G.; Pedersen, J. S.; Otzen, D. E. SDS-Induced Fibrillation of Alpha-Synuclein: An Alternative Fibrillation Pathway J. Mol. Biol. 2010, 401, 115-133
16. Anderson, V. L.; Webb, W. W.; Eliezer, D. Interplay between Desolvation and Secondary Structure in Mediating Cosolvent and Temperature Induced Alpha-Synuclein Aggregation. Phys. Biol. 2012, 9, 056005-0560013.
17. Ladiwala, A. R. A.; Bhattacharya, M.; Perchiacca, J. M.; Cao, P.; Raleigh, D. P.; Abedini, A.; Schmidt, A. M.; Varkey, J.; Langen, R.; Tessier, P. M. Rational Design of Potent Domain Antibody Inhibitors of Amyloid Fibril Assembly Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 19965-19970
18. Volles, M. J.; Lansbury, P. T. Zeroing in on the Pathogenic Form of Alpha-Synuclein and Its Mechanism of Neurotoxicity in Parkinson's Disease Biochemistry 2003, 42, 7871-7878
19. Danzer, K. M.; Haasen, D.; Karow, A. R.; Moussaud, S.; Habeck, M.; Giese, A.; Kretzschmar, H.; Hengerer, B.; Kostka, M. Different Species of Alpha-Synuclein Oligomers Induce Calcium Influx and Seeding J. Neurosci. 2007, 27, 9220-9232
20. Winner, B.; Jappelli, R.; Maji, S. K.; Desplats, P. A.; Boyer, L.; Aigner, S.; Hetzer, C.; Loher, T.; Vilar, M.; Campionic, S. In Vivo Demonstration That Alpha-Synuclein Oligomers Are Toxic Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 4194-4199
21. Hinault, M. P.; Cuendet, A. F. H.; Mattoo, R. U. H.; Mensi, M.; Dietler, G.; Lashuel, H. A.; Goloubinoff, P. Stable Alpha-Synuclein Oligomers Strongly Inhibit Chaperone Activity of the Hsp70 System by Weak Interactions with J-Domain Co-Chaperones J. Biol. Chem. 2010, 285, 38173-38182
22. Cremades, N.; Cohen, S. I. A.; Deas, E.; Abramov, A. Y.; Chen, A. Y.; Orte, A.; Sandal, M.; Clarke, R. W.; Dunne, P.; Aprile, F. A. Direct Observation of the Interconversion of Normal and Toxic Forms of Alpha-Synuclein Cell 2012, 149, 1048-1059
23. Kang, L. J.; Wu, K. P.; Vendruscolo, M.; Baum, J. The A53T Mutation Is Key in Defining the Differences in the Aggregation Kinetics of Human and Mouse Alpha-Synuclein J. Am. Chem. Soc. 2011, 133, 13465-13470
24. Losasso, V.; Pietropaolo, A.; Zannoni, C.; Gustincich, S.; Carloni, P. Structural Role of Compensatory Amino Acid Replacements in the Alpha-Synuclein Protein Biochemistry 2011, 50, 6994-7001
25. Citron, M. Alzheimer's Disease: Strategies for Disease Modification Nat. Rev. Drug Discovery 2010, 9, 387-398
26. Metallo, S. J. Intrinsically Disordered Proteins Are Potential Drug Targets Curr. Opin. Chem. Biol. 2010, 14, 481-488
27. Yamin, G.; Ono, K.; Inayathullah, M.; Teplow, D. B. Amyloid Beta-Protein Assembly as a Therapeutic Target of Alzheimer's Disease Curr. Pharm. Des. 2008, 14, 3231-3246
28. Zhu, M.; De Simone, A.; Schenk, D.; Toth, G.; Dobson, C. M.; Vendruscolo, M. Identification of Small-Molecule Binding Pockets in the Soluble Monomeric Form of the Abeta42 Peptide J. Chem. Phys. 2013, 139, 035101
29. Chiti, F.; Stefani, M.; Taddei, N.; Ramponi, G.; Dobson, C. M. Rationalization of the Effects of Mutations on Peptide and Protein Aggregation Rates Nature 2003, 424, 805-808
30. Tartaglia, G. G.; Pawar, A. P.; Campioni, S.; Dobson, C. M.; Chiti, F.; Vendruscolo, M. Prediction of Aggregation-Prone Regions in Structured Proteins J. Mol. Biol. 2008, 380, 425-436
31. Camilloni, C.; De Simone, A.; Vranken, W. F.; Vendruscolo, M. Determination of Secondary Structure Populations in Disordered States of Proteins Using Nuclear Magnetic Resonance Chemical Shifts Biochemistry 2012, 51, 2224-2231
32. Marsh, J. A.; Singh, V. K.; Jia, Z. C.; Forman-Kay, J. D. Sensitivity of Secondary Structure Propensities to Sequence Differences between Alpha- and Gamma-Synuclein: Implications for Fibrillation Protein Sci. 2006, 15, 2795-2804
33. Kang, L. J.; Moriarty, G. M.; Woods, L. A.; Ashcroft, A. E.; Radford, S. E.; Baum, J. N-Terminal Acetylation of Alpha-Synuclein Induces Increased Transient Helical Propensity and Decreased Aggregation Rates in the Intrinsically Disordered Monomer Protein Sci. 2012, 21, 911-917
34. Fauvet, B.; Fares, M. B.; Samuel, F.; Dikiy, I.; Tandon, A.; Eliezer, D.; Lashuel, H. A. Characterization of Semisynthetic and Naturally N-Alpha-Acetylated Alpha-Synuclein in Vitro and in Intact Cells Implications for Aggregation and Cellular Properties of Alpha-Synuclein J. Biol. Chem. 2012, 287, 28243-28262
35. Maltsev, A. S.; Ying, J. F.; Bax, A. Impact of N-Terminal Acetylation of Alpha-Synuclein on Its Random Coil and Lipid Binding Properties Biochemistry 2012, 51, 5004-5013
36. Bulawa, C. E.; Connelly, S.; Devit, M.; Wang, L.; Weigel, C.; Fleming, J. A.; Packman, J.; Powers, E. T.; Wiseman, R. L.; Foss, T. R. Tafamidis, a Potent and Selective Transthyretin Kinetic Stabilizer That Inhibits the Amyloid Cascade Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 9629-9634
37. Zhu, M.; De Simone, A.; Schenk, D.; Toth, G.; Dobson, C. M.; Vendruscolo, M. Identication of small-molecule binding pockets in the soluble monomeric form of the A42 peptide J. Chem. Phys. 2013, 139, 035101